Taoyuan, Taiwan

Wen-Chih Chuo

This inventor holds 1 USPTO granted patent. Top assignee: Sci Pharmtech Inc.. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wen-Chih Chuo in Pharmaceutical Chemistry

Introduction

Wen-Chih Chuo is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of metal salts of valproic acid. His innovative approach has the potential to enhance the efficiency and safety of pharmaceutical processes.

Latest Patents

Wen-Chih Chuo holds a patent for a method titled "Method for preparing metal salt of valproic acid." This invention provides a simple, safe, and more efficient process for preparing metal salts of valproic acid. The process involves mixing valproic acid with a metal hydroxide, either in dry solid form or as an aqueous solution, in a drier to form a reaction mixture. Subsequently, water produced during the mixing process is removed from the reaction mixture to obtain the desired metal salts of valproic acid. He has 1 patent to his name.

Career Highlights

Wen-Chih Chuo is associated with Sci Pharmtech Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving processes that can lead to better drug formulations and enhanced therapeutic outcomes.

Collaborations

Wen-Chih Chuo collaborates with talented individuals in his field, including Weichyun Wong and Yon-Lian Wu. Their combined expertise contributes to the advancement of pharmaceutical technologies.

Conclusion

Wen-Chih Chuo's contributions to the field of pharmaceutical chemistry exemplify the importance of innovation in drug development. His patented method for preparing metal salts of valproic acid showcases his commitment to enhancing pharmaceutical processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…